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Abstract
Background: Antimicrobial peptides attract considerable interest as novel agents to combat infections. Their
long-time potency across bacteria, viruses and fungi as part of diverse innate immune systems offers a solution
to overcome the rising concerns from antibiotic resistance. With the rapid increase of antimicrobial peptides reported
in the databases, peptide selection becomes a challenge. We propose similarity analyses to describe key properties that
distinguish between active and non-active peptide sequences building upon the physicochemical properties of
antimicrobial peptides. We used an iterative supervised machine learning approach to classify active peptides
from inactive peptides with low false discovery rates in a relatively short computational search time.
Results: By generating explicit boundaries, our method defines new categories of active and inactive peptides
based on their physicochemical properties. Consequently, it describes physicochemical characteristics of similarity
among active peptides and the physicochemical boundaries between active and inactive peptides in a single
process. To build the similarity boundaries, we used the rough set theory approach; to our knowledge, this is the
first time that this approach has been used to classify peptides. The modified rough set theory method limits the
number of values describing a boundary to a user-defined limit. Our method is optimized for specificity over
selectivity. Noting that false positives increase activity assays while false negatives only increase computational
search time, our method provided a low false discovery rate. Published datasets were used to compare our rough
set theory method to other published classification methods and based on this comparison, we achieved high
selectivity and comparable sensitivity to currently available methods.
Conclusions: We developed rule sets that define physicochemical boundaries which allow us to directly classify
the active sequences from inactive peptides. Existing classification methods are either sequence-order insensitive
or length-dependent, whereas our method generates the rule sets that combine order-sensitive descriptors with
length-independent descriptors. The method provides comparable or improved performance to currently available
methods. Discovering the boundaries of physicochemical properties may lead to a new understanding of peptide
similarity.
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Background
In the US, over 23,000 deaths each year are associated
with drug-resistant bacterial infections [1]. These types
of infections are central to the projected increase in
deaths globally by 2050, which are expect to reach 10
million annually [2, 3]. The rise of antibiotic-resistant
bacteria has prompted increasing interest in antimicro-
bial peptides as a solution to this critical issue [4]. Over
2800 antimicrobial peptides have been discovered from
natural sources in the last decade [5–11]. Antibacterial
peptides derived from these natural sequences have
shown both broad-spectrum and improved activity
against targeted bacteria [12–16]. Antibacterial peptide-
mimics are introduced as another source to the existing
peptide libraries by incorporating additional backbone
chain atoms for more structural flexibility and resist-
ance to protease degradation [17–20]. This list extends
by exploring the post-translationally modified anti-
microbial peptides offering chemical properties beyond
the naturally occurring amino acids [21, 22].
While many antimicrobial peptides have been discov-
ered at the laboratory bench, computational methods have
been integrated into this search to find many more candi-
dates. Encrypted antimicrobial peptides are an example in
which known active peptides are queried against DNA re-
positories to find new antimicrobial peptides [23]. Among
many methods, grammar-based methods and regular-
expression-based match sequence patterns are used to
identify functional similarity [24, 25]. Computer-aided
molecular design [26–29] approaches using quantitative
sequence activity relationships [30–33] (QSAR) predict
the antibacterial level of peptides given key chemical prop-
erties. Artificial neural networks (ANN) have been used
both to generate new sequences and to distinguish be-
tween active and inactive sequences [25, 34–37]. They are
often used in the classification of antimicrobial peptide se-
quences [7, 38]. While ANNs are flexible enough to model
many kinds of complex relationships, they lack transpar-
ency about how classification choices are made. Determin-
ing the boundaries of the similar antimicrobial peptide
clusters remains difficult despite many existing machine
learning methods.
Due to the ongoing need for improved antimicrobial
peptide selection and design, many classification ap-
proaches have been developed with supervised machine
learning methods. A recent review by Porto et al con-
trasts two different kinds of sequence representations
for antibacterial classification [25]. The first kind of rep-
resentation preserves the order of the sequence which
tends to lead to length-dependent predictions [39]. False
positives may be produced if the overall chemical prop-
erties of an antibacterial peptides are changed by adding
amino acids with contradictory chemical properties. The
second kind of sequence representation preserves overall
sequence properties which tends to lead to order-in-
sensitivity. False positives may be produced if the order
of an active peptide is scrambled [24].
AntiBP [40] was one of the first online available ser-
vices for antibacterial peptide prediction. AntiBP uses a
sliding window of 15 residues to predict the classifica-
tion using support vector machines (SVM) [41], quanti-
tative matrices (QM) [42] and artificial neural networks
(ANN) [43]. The strength of this approach is that the
order of amino acids impacts the prediction. However,
the weakness to having a constant window of amino
acids is that the predictions are peptide-length dependent
[39]. To overcome the peptide length dependence, an-
other method CAMP (Collection of Antimicrobial
Peptides) [44] was employed to use descriptors that
summarize composition, physicochemical properties
and structural features of the peptides. CAMP uses
multiple machine learning approaches for these fea-
tures such as SVM [45], ANN [46, 47], discriminate
analysis (DA) [48] and random forest (RF) [49]. However,
the descriptor approach is insensitive to the sequence
order arrangement. For example, full-length sequence de-
scriptors can be sensitive to the overall charge of a peptide
but not its charge distribution. iAMP-2 L (antimicrobial
peptide prediction two-level) [50] partially addresses the
order insensitivity by calculating the autocorrelation of
amino acid property values within the amino acid se-
quence. Other descriptors do not account for the order of
the sequence [24]. Because the iAMP-2 L classification al-
gorithm is based on a fuzzy K-nearest neighbor algorithm,
clusters that are invariant for descriptors that include cor-
relations would be sequence-order insensitive. This ap-
proach is also sequence-order insensitive to sequence
rearrangements that preserve the correlation structure
from the original peptide. Evolutionary Feature Construc-
tion [51–53] (EFC) method addresses this need by achiev-
ing order-sensitive classification by combining order
sensitivity and length independence by selecting common
chemical property sequence patterns for antimicrobial
peptides. Length-independent classification is achieved
with a support-vector machine method through physico-
chemical descriptors selected by FCBF (Fast-Correlation
Based Filter selection) [52]. While this method does com-
bine order-sensitivity and length-independence, it does
not completely address either of these issues. Order-in-
sensitivity is possible based on the rearrangements of
amino acids that are indistinguishable by the pattern rec-
ognition scheme of compressing 20-amino acids into four
categories.
We propose a novel method that addresses order sen-
sitivity by calculating the physicochemical properties of
sub-sequences in addition to using descriptors of physi-
cochemical properties for length independence. Our
method therefore combines order-sensitivity and length
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independence as a new approach. We analyze these de-
scriptors using rough set theory (RST). Rough set theory
is a heuristic method for discovering rules, which distin-
guish between outcomes. These rules show which data
features and data values are useful to distinguish be-
tween outcomes. To the best of our knowledge, RST has
not yet been studied to classify peptide or protein se-
quences based on their activity. Our RST implementa-
tion uses features that summarize the physicochemical
properties of the full-length sequences, which are se-
quence-order insensitive, and features which summarize
constant-length subsequences, which are sequence-order
sensitive. RST selects combinations of both kinds of de-
scriptors into a single rule. Each rule defines its own clus-
ter including the classification of the peptide’s activity or
inactivity.
Using a rough set theory approach that combines the al-
gorithm of MLEM2 (modified learning from examples
module, Version 2) [54] with the algorithm IRIM (Inter-
esting Rule Induction Module) [55], we developed a
method that investigates the sequence-function relation-
ships. The main difference in from other RST methods is
that it uses local coverings to generate rules, which are dif-
ferent from the lower and upper approximations in the
basic RST methodology. IRIM is a method that optimizes
for rules that have the most training set sequences that
apply. This is different from MLEM2 in that IRIM may
not provide a rule that applies to every training set se-
quence. We achieve high specificity performance with our
condition-limit number MLEM2 with the fewest chemical
property features among benchmarked methods. Our
method was tested against publicly available prediction
servers CAMP AMP prediction [9], iAMP-2 L [50], and a
motif-searching algorithm EFC method [51, 52] with and
without FCBF. The approach produces physicochemical
boundaries that create definitions of similarity among
antimicrobial and non-antimicrobial peptides.
Results
The explosion of available antimicrobial peptides brings
the new challenge of selecting which antimicrobial pep-
tides to use [38, 56–58]. With the large increase in the
number of available peptides, there is an opportunity to
classify peptides with respect to their similarity. We de-
fine similarity by the physicochemical properties of the
peptides, which we show can differentiate between active
and inactive peptides. Each rule generated is a category
of peptides with boundaries of physicochemical proper-
ties chosen so that no rule category is a mixture of active
and inactive peptides beyond an allowed limit. We gen-
erate rules until all peptides in the training set are cov-
ered by at least one category.
Training sets are formatted as data tables; Table 1 is
provided as an example to summarize these data sets.
The first column is the identity column, which presents
the sequences of the peptide. Each row of the data
table corresponds to one peptide sequence. The feature
columns list the corresponding values for each peptide
depending on the amino acid properties and the sum-
marizing function. The final column is the label of
antibacterial activity. A condition is a value interval for
a feature. The intersection of conditions is a rule, as
shown in Fig. 1.
Evaluating the performance of the rules being gener-
ated is performed by calculating the Pr, the training set
accuracy performance of the rule. The Pr is the ratio of
the size of the sets of peptides described by the intersec-
tion of all the conditions in the rule that meet the tar-
geted label to all the peptides described by the
intersection of the conditions (Eq. 1). The CLN value is
the user-defined condition-limit number, which limits
the number of conditions in each of the rules. The value
of Pr must be at or above α, the user-defined minimum
training accuracy a rule must have to be included in the
rule set.
Table 1 Schematic Data table representing the training data set before feature correlation analysis. The three sections of the table
are the sequences from iAMP-2 L training set [50], the features derived from the 544 amino acid properties in the AAindex1 [63],
and the classification label of antibacterial activity from the positive or negative training data set. an denotes a sequence, bn
indicates the sum of the sequence for an AAindex1 property, cn indicates the mean and dn indicates the maximum sum of three
adjacent residues in the sequence
Sequence Sum of Mean of Window of Antibacterial
ActivityA1 …A544 A1 …A544 A1 …A544
a1 (b1)1…(b1)544 (c1)1…(c1)544 (d1)1…(d1)544 Active
… … … … Active
a1274 (b1274)1…(b1274)544 (c1274)1…(c1274)544 (d1274)1…(d1274)544 Active
a1,275 (b1,275)1…(b1,275)544 (c1,275)1…(c1,275)544 (d1,275)1…(d1,275)544 Inactive
… … … … Inactive
a 2714 (b 2714)1…(b 2714)544 (c 2714)1…(c 2714)544 (d 2714)1…(d 2714)544 Inactive
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In using the rough set theory approach, we modified
existing approaches by combining the features of
MLEM2 (modified learning from examples module, Ver-
sion 2) method [59, 60] with a feature of the module
IRIM (Interesting Rule Induction Module) to potentially
improve our selectivity and specificity [61]. We modified
the MLEM2 method by adding the ability to limit the
condition number for each of the rules, a feature of
IRIM. Because the IRIM method exhaustively searches
all possible rules given the number of conditions, it can-
not be used for large numbers of conditions or large
numbers of peptides because the runtime grows expo-
nentially with the number of conditions.
Our modified MLEM2 method uses the heuristics of
the MLEM2 method to select condition combinations
with a run time that grows polynomially in the number
of peptides and in the number of conditions. Our modi-
fied method includes a defined-condition number (CLN)
which combines the polynomially-bound worst-case run-
time of MLEM2 with the set number of conditions of
IRIM. Because a small number of conditions are selected
from the available number of conditions, CLN-MLEM2
is an embedded feature selection method [62]. It at-
tempts to use the most relevant conditions to describe
the boundaries. The relevance of a condition is the num-
ber of peptides that are described by it in the training
set. The CLN-MLEM2 method selects rules based on a
user-defined minimum accuracy referred to as α (0 ≤ α ≤
1). Using higher values of α generates fewer rules with
higher Pr values of training accuracy. Using lower values
of alpha generates more rules with lower Pr values of
training accuracy. CLN-MLEM2 generates rules until all
peptides in the training set have at least one rule that
applies to it. The collection of all rules for either active
peptides or inactive peptides is called a rule set.
To begin the defined-condition number MLEM2
(Modified Learning from Experience Module 2) method,
we generate multiple summaries of the amino acid se-
quences of the given active and inactive peptides by
selecting non-correlated amino acid properties in the
AAindex1 [63] (Amino Acid index 1). Among the 544
properties of the AAindex1, many of the properties are
highly correlated. The autocorrelation matrix of the
AAindex1 properties was calculated as the pairwise
Pearson correlation value of each pair of properties in
the index. The heat map of correlation values for the
autocorrelation matrix is shown in Fig. 2a. Positive cor-
relation is magenta and negative correlation is teal.
Non-correlated amino acid property pairs are white. The
autocorrelation matrix shows that most amino acid
properties are highly correlated. We studied how many
amino acid properties are below a correlation threshold
for all other amino acid properties (Fig. 2b). We per-
formed 60 repetitions with random initial properties of
eliminating properties more correlated than a threshold.
We found a very tight trend of how many uncorrelated
properties there are for a given cut-off value. For further
study, we selected a correlation cut-off of 0.65, which re-
sulted in 74 properties remaining from the original 544
properties.
We seek to combine overall sequence chemical
properties and motif properties to be able to account
for how all of the residues may affect the chemical
properties while still retaining the ability to separate
classifications based on the ordering of the residues. If
only chemical properties are evaluated by the sum or
mean of the whole sequence, then the rules generated
are sequence-order insensitive. By considering sub-se-
quences of the peptides, then the ordering of the
chemical properties within the sequence can be used
as a feature. We calculate two types of sequence prop-
erty summaries from the selected amino acid proper-
ties in the AAindex1 (Amino Acid index 1) after
removing the correlated amino acid chemical proper-
ties. First, we calculate overall property summaries as
the mean and average of the properties of the amino
acids present in the sequence. Secondly, we calculate
motif properties as the maximal subsequence sum of
a given length of the amino acid sequence. Our
CLN-MLEM2 method can combine overall sequence
properties and motif properties within a single rule.
Each rule forms a class of either active or inactive
peptides.
Fig. 1 Rough Set Theory Rule Generation. A) Venn diagram of active
and inactive peptides. A rule (R1) is the intersection of conditions
(C1and C2). Each rule must be selective for either active or
inactive peptides. The minimum accuracy allowed for a rule is a
user-defined parameter α. B) Venn diagram showing multiple
rules as the intersection of conditions in 2-D space. The
selection of conditions that lead to rules is a feature selection
process that chooses the most relevant conditions to describe the
physicochemical boundaries. A rule set is the collection of all rules
describing the boundaries for either activity or inactivity
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We used previously studied, publicly available datasets
of antimicrobial peptides [50, 64] to test our method of
finding physicochemical boundaries for antibacterial ac-
tivity. See Table 2 for the inducted rule category with the
largest membership of the studied dataset. The rule cat-
egory is the conjunctive expression of each of the con-
ditions up to the user-defined condition-limit number
(CLN) with the rule applying to antimicrobial peptides
whose property values are within the range of the
values given in Table 2 (Eq. 2). This rule has a high se-
lectivity of 97.8% with a false discovery rate of 2.2%. All
sequences that do not match any rule for the applied











Protein and peptide sequence-based classification methods
have been extensively developed to improve the under-
standing of the functionality of polypeptides [65, 66]. By
using rough set theory, our method builds rules that dis-
tinguish between active antibacterial peptides from in-
active antibacterial peptides. The developed method was
benchmarked against methods including a recently pub-
lished method EFC [52], based on motif-recognition, as
well as against a larger set of methods from publicly avail-
able prediction servers. The first benchmark test is a ten-
fold cross validation on a dataset used in previous studies
[52, 64] with the positive sequences clustered from the
APD2 (Antimicrobial Peptide Database 2) [10] to 115
clusters and the negative sequences from the PDB [67]
clustered to 116 clusters. Each cluster is represented by
one sequence. The results were compared with EFC-based
methods and support vector machines given subsequences
of lengths 5 to 8 amino acids. Table 3 demonstrates that
Table 2 Rough set theory rules generated with maximum
support from large training dataset. The first rule describes
antibacterial sequences. The accuracy of this rule is 97.8%
(446/456) for the peptides that met the conditions from
either the dataset from Xiao, et al [50] or the dataset from
Fernandes, et al. [64]
Calculation AAindex1 Property Lower Value Upper Value
Window 3 NAKH900111 31.21 48.66
Window 3 FINA910104 3.45 5.10
Window 3 KUMS000101 23.6 28.20
Sum GEIM800102 12.68 39.90
Window 3 VASM830102 1.67 2.12
Window 3 QIAN880139 0.38 0.98
Sum FAUJ880112 0 3
Sum CHAM820102 −0.61 19.51
Fig. 2 Auto-Correlation and Selection of AAindex1 Properties. a Auto-correlation plot of 544 different AAindex1 properties. Magenta represents
positive correlation, cyan represents negative correlation and white represents the lack of correlation between properties. b Remaining number of
AAindex1 properties following filtering by cut-off value for the absolute value of correlation
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our method has high selectivity and accuracy in compari-
son to the performance of the SVM methods, and com-
parable selectivity and accuracy in comparison to the EFC
method. A trend of decreasing Mathew’s Correlation Co-
efficient (0 for random guessing and 1 for perfect perform-
ance) as the length of the subsequence increases is seen in
Table 3. Our subsequences in CLN-MLEM2 are 3 amino
acids long and may have helped to contribute to our im-
proved performance for using a single length of subse-
quences instead of combining four different lengths in the
EFC method.
We further tested our modified MLEM2 method against
a larger variety of classification methods. The second
benchmarking test uses the iAMP-2 L dataset [50]. Like
the dataset used for the first benchmark, this dataset is de-
rived from the APD2 database. However, instead of choos-
ing a single sequence from each cluster, the sequences
were narrowed by removing sequences with greater than
40% similarity as measured by CD-HIT [68] only with
cluster of more than 250 sequences. This resulted in a
testing positive dataset of 848 unique sequences. The
negative sequences were from a UniProt search of cyto-
plasmic proteins, also with less than 40% similarity. 2405
unique sequences were included in the negative dataset.
The positive training data set was the S1 set (“Antibacter-
ial”) from iAMP-2 L, which has 1274 unique sequences.
The negative training set of data was the non-AMP data
set from iAMP-2 L, which has 1440 unique sequences.
While our method has comparable selectivity in classi-
fication to current state-of-the-art method, our method
is among the best in specificity (Table 4). The combin-
ation evolutionary algorithm with chemical properties
(EFC + 307-FCBF: EFC combined with FCBF (Fast Correl-
ation Based Features) using 307 features) is the only other
state-of-the-art method with specificity that is comparable
to ours. We achieve similar specificity using 74 AAindex1
features instead of 307 AAindex1 features. Removing the
length-independent representation from the EFC method
(EFC-FCBF: EFC without FCBF) results in almost no loss
of sensitivity, but a loss of 6% in selectivity. Removing
the order-sensitive representation for EFC in Table 2
results in lower sensitivity and selectivity performance
(MCC = 0.54). While the datasets are different, between
Table 3 and Table 4 results, the difference in the indi-
vidual components of the EFC algorithm compared to
the combined algorithm shows a dramatic improve-
ment when integrating order-sensitive and length inde-
pendent sequence representations. Our CLN-MLEM2
method integrates these two types of representations at
its most basic level of output, the rule.
Our method has high specificity and similar accuracy
for antibacterial classification as other current methods.
When using a classification method for the discovery of
antimicrobial peptides, the specificity of the method is
more important than its selectivity [69]. Our method
prioritizes specificity with low false discovery rate (FDR)
by classifying sequences that do not meet any rule in the
applied rule set as inactive (Fig. 3). In fact, there is only
one method, which provides lower FDR compared to
our method, i.e. EFC + 307-FCBF. However, our method
results in similar specificity starting with fewer physico-
chemical properties. The robustness of this method may
be potentially improved with ensemble learning and vot-
ing scheme approaches. If our method provides unique
descriptions of activity, then it will reduce the overall
Table 3 Performance of rough set theory rule induction compared
to motif-search in 10-fold cross validation
Method Sensitivity (%) Specificity (%) MCC
5-kmer SVM 75.7 75.0 0.54
6-kmer SVM 74.8 74.1 0.46
7-kmer SVM 73.0 72.4 0.40
8-kmer SVM 73.0 72.4 0.36
EFC-FCBF 87.1 87.2 0.76
CLN-MLEM2 86.9 86.3 0.75
Table 4 Performance comparison among prediction servers for
antimicrobial peptides, a motif-based classification method and
rough set theory approach
Method Sensitivity (%) Specificity (%) MCC
CAMP SVM 95.8 39.8 0.43
CAMP RF 97.1 33.5 0.40
CAMP ANN 89.1 70.9 0.61
CAMP DA 94.1 49.5 0.49
iAMP-2 L 97.7 92.0 0.90







Fig. 3 False discovery rates of comparative antimicrobial peptide
classification methods. CLN-MLEM2 achieves a low false discovery rate
among currently available antimicrobial peptide classification methods
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false discovery rate of the ensemble method and voting
scheme approaches.
CLN-MLEM2 has been shown to be useful for the
learning task of predicting antibacterial activity from a
peptide sequence. This learning task is related to multi-in-
stance learning. A classic literature example of a multi-in-
stance learning problem is in drug activity prediction [70].
Active molecules have at least one conformation that in-
teracts with a drug target, while inactive molecules have
none. The challenge is to identify which conformations
interact with the drug target. Each drug has one molecular
formula, but it can have many conformations. Each pep-
tide also has one sequence but many physicochemical
property values. The CLN-MLEM2 method has found
the most relevant physicochemical property features
that relate to the activity of the peptide sequence.
This CLN-MLEM2 method can also be applied to the
multi-instance learning case of describing the confor-
mations of peptides are active.
Our method also acts as an embedded feature selec-
tion tool by limiting the physicochemical properties in
the rules to a user-defined number [62]. This embedded
feature selection property may make CLN-MLEM2 use-
ful for feature selection for other methods in the field,
with the capability of setting the limit of the number of
features to select. Our proposed method, CLN-MLEM2
has a low false discovery rate compared to comparative
antimicrobial peptide methods as shown in Fig. 3. EFC
method also has a low false discovery rate when includ-
ing the physicochemical properties, but a doubled false
discovery rate when the pattern recognition component
is used alone.
A decrease in selectivity of the classification will cause
longer computer search times, while a decrease in speci-
ficity will increase the number of necessary experimental
activity assays. Since the cost of experimentally testing
peptides is much greater than the computational time of
searching for antimicrobial peptides, methods that have
high specificity are preferred. In addition to the high
specificity of our method, our method creates categories
of antimicrobial peptides. Categorization of peptides aids
in the selection and in the design of antimicrobial pep-
tides by providing similarity groupings according to
physicochemical property boundaries. Peptides that
match multiple active categories can combine more
physicochemical property values associated with activity.
Conclusion
The increase in multidrug resistant bacteria usage has
prompted an intense search for agents that can be used
to treat infectious diseases. There is growing interest in
antimicrobial peptides as novel agents to treat infec-
tions, and this interest has led to an exponential growth
of known antimicrobial peptides. However, peptide
selection is becoming another challenge with the dras-
tic increase in the number of these peptides discovered
from natural resources, their modified version as well
as computational derived ones. We developed a method,
CLN-MLEM2, for generating rule sets to describe the
similarity among antimicrobial peptides by physicochemi-
cal boundaries. Our CLN-MLEM2 method allows the user
to limit the number of physicochemical properties used to
set the boundaries. Discovering where the boundaries of
physicochemical properties are among active peptides
generates new categories of antimicrobial peptides.
Our approach simultaneously groups peptides and clas-
sifies them. We benchmark our rule set performance to
other classification methods. Some available classification
methods are either sequence-order insensitive or length-
dependent. The rule sets our method generates combine
order-sensitive descriptors with length-independent de-
scriptors. We achieve comparable or improved specifi-
city and selectivity to currently available methods with
lower false discovery rates. The high specificity of our
method aids novel antibacterial peptide discovery be-
cause a low false discovery rate reduces the number of
bacterial assays.
Methods
In this study we test our rough set theory classification
method to differentiate antibacterial peptides from APD2
[10] (Antimicrobial Peptide Database 2) and randomly se-
lected peptides from the UniProt database [71, 72]. These
benchmark datasets are available online [50, 64].
Rule induction by the MLEM2 algorithm
The MLEM2 rule induction method [54] is a classifica-
tion method based on a rough set theory approach that
uses local approximations of concepts to generate rules
when the available attributes cannot perfectly separate
the data. A local approximation is finding collections of
conditions that cover a concept with an accuracy re-
quirement parameter α. We use a modified MLEM2 ver-
sion that combines the polynomial run time growth rate
of MLEM2 with the defined-condition number of the
IRIM (Interesting Rule Induction Method) to find rules
with small numbers of conditions in large datasets with
many attributes. IRIM has an exponential run time
growth rate with respect to attribute number. We set
the maximum number of conditions to be eight (8).
Conditions are intervals of feature values. Each peptide
sequence has one value for each feature. Rules are con-
junctive expressions of conditions.
Figure 4 shows the overall process for building rules.
Rules are built from conditions that contain the max-
imum number of peptide sequence of the desired anti-
bacterial label. Ties are broken by the conditions that
have the highest percentage of peptide sequences with
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the desired antibacterial label. Rules are refined by nar-
rowing the interval of an included condition or by add-
ing a new condition to the conjunctive expression. Rules
are simplified by omitting redundant conditions whose
loss still results in a rule with no loss of accuracy. The
minimum accuracy that a valid rule must have is a
user-defined value, α. In this study, α is set to the accur-
acy of the majority class rule, which is to label all pep-
tides with the non-antibacterial class.
Table 5 shows a compact data table that is consisted of
six sequences with two features to illustrate method-
ology. The most relevant condition among the two fea-
tures for active antibacterial activity is the sum of the
positive charge from 1 to 3, relating to all three active
peptides. This condition does not form a rule, however
there is an inactive sequence with a sum of positive
charge of 1. To distinguish between inactive and active
between these two sequences, the second feature of the
sum of negative charges is considered. The intersection
of the conditions of the sum of positive charge from 1 to
3 and the sum of negative charge from 0 to 1 is a valid
rule for labeling active peptides for this data table. This
rule forms a boundary between active and inactive
peptides for this data table. In larger data tables, rules
may also form boundaries between active peptides or be-
tween inactive peptides because different features may
be relevant for the activity for different sets of peptides.
Correlated AAindex1 property removal
The AAindex1 has 544 properties with one value for
each of the twenty naturally occurring amino acids [63].
A database of all properties is available in the R package
‘seqinr’ [73]. We constructed an autocorrelation matrix
of these properties to provide pairwise correlation com-
parisons for all 544 properties. We filtered properties
using an absolute correlation value cutoff. We random-
ized which property to keep by randomizing the order in
which the properties were compared.
Performance descriptions
In binary classification there are two different descrip-
tions of performance based on the two possible error
types, false positives and false negatives. Sensitivity refers
to the likelihood of correctly predicting a positive result,
while specificity refers to the likelihood of correctly pre-
dicting a negative result. Sensitivity deals with avoiding
false positives, while specificity deals with avoiding false
negatives. Selectivity, which can be directly derived from
specificity, is the likelihood of incorrectly predicting a
negative result, a false negative. Further details about
performance measures are included in Additional file 1.
Additional file
Additional file 1: Feature Generation and Performance Measure
Methods (DOCX 30 kb)
Abbreviations
AAindex1: Amino acid index 1; AMP: Antimicrobial peptide; ANN: Artificial
neural network; APD2: Antimicrobial peptide database 2; CAMP: Collections
of antimicrobial peptides; CLN: Condition limit number; DA: Discriminant
analysis; EFC + 307-FCBF: Evolutionary feature construction and fast
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FFPVIGRILNGIL 1 0 Active
KFHEKHHSHRGY 3 1 Active
GNNRPVYIPQPRPPHPRL 3 0 Active
QDVDHVFLRF 1 2 Inactive
QQDYTGWMDF 0 1 Inactive
QLTFTSSWG 0 0 Inactive
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